Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
Clinical trial NCT04428008 · COMPLETED
Trial details
- NCT number
- NCT04428008
- Sponsor
- William B. Ershler, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-12
- Primary completion
- 2023-01-19
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.